Tiziana Life Sciences is a NASDAQ-listed clinical-stage biotechnology company which pays close attention to transformational technology enabling alternative methods for immunotherapy. This company has reactivated its strategic plan to redomicile to Bermuda during the operation.

Tiziana Life Sciences specialises in building up a variety of transformative therapies for neurodegenerative and lung diseases. The clinical system of this company consists of drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. With the mission to bring breakthrough therapies to patients, this organization hopes to treat Secondary Progressive Multiple Sclerosis, ALS, Alzheimer's, and other CNS indications. Crohn's Disease, lung diseases and optimize health outcomes. Particularly, highly qualified executives lead Tiziana Life Sciences with extensive drug development and commercialization experience.

Tiziana Life Sciences is fostering transformational formulation technologies, enabling to switch from traditional routes to alternative ones of immunotherapy to simplify local sites of action. This can be exemplified by nasal, oral and inhalation administrations that target neurodegenerative and lung diseases. On top of that, this company always believe that employees have the potential to alter the way immunotherapies are currently conducted.

Founded: 1998

Location: Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda

Website: https://www.tizianalifesciences.com/

AbbVie is a biotech company registered in Bermuda and gradually becomes one of the top institutions in this nation. It is also ranked 6th on the list of the largest biotech companies by revenue. This company was founded in 2013 when it became a separate organization from Abbott. The name "AbbVie" represents a proud connection to that legacy.

With a mission to discover and deliver innovative medicines, AbbVie is devoted to finding out useful methods to solve serious health issues today and address the medical challenges in the long term. Besides that, this company also constantly strive to have a considerate impact on people’s lives across crucial key therapeutic areas such as immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, as well as products and services across its Allergan Aesthetics portfolio.

Since its establishment in 2013, the mission of AbbVie has not fluctuated over the years. The combination of focused innovation and commercial scale brings differentiated goods and amenities to the market that have a range of benefits to patients, customers and healthcare providers.

Founded: 2013

Location: 4 Burnaby Street Hamilton, Pembroke, HM 11 Bermuda

Website: https://www.abbvie.com/

CariGenetics is an early-stage genomics company that has raised the first one million dollars of sponsorship with assistance from the Bermuda Investor Community. This institution aims to unlock the Caribbean genome to improve health outcomes for all, and even help to integrate climate change protections.

Although an upward trend is currently witnessed regarding the detrimental potential for AI’s runaway technology, CariGenetics Group has already made use of its groundbreaking in healthcare, reshaping the diagnoses, treatments and monitoring of patients. On top of that, the advent of novel trends in healthcare depicts that CariGenetics Group is trying to find new ways to develop drugs, which are more targeted to individuals' unique demands than a one-size-fits-all approach. This is called “precision medicine”. Other than that, this company is also transforming the way that other biotech institutions develop medicines including non-European data. Apparently, the aiming operation of CariGenetics is geared towards making sure of health equity by fostering trust through transparency, empowerment through knowledge and innovation through genetics.

With the development of the CariGenetics Group, Carika Weldon, a Bermudian geneticist, promises that this company will go down the flow of healthcare money out of Bermuda’s economy and become a lynchpin in the novel Bermuda’s healthcare renovation. Therefore, it is listed as one of the largest biotech organizations in Bermuda.

Founded: 2022

Location: Hamilton, Pembroke, Bermuda

Website: https://carigenetics.com/